Table 1.

Clinical Trials of Hydrogels in Gastrointestinal Cancer.

Number	ClinicalTrials.gov identifier	Condition/Disease	Intervention/Treatment	Phase
1	NCT04595266	Colorectal cancer metastatic	Drug: FOLFOX regimen Biological: Anti-EGFR or Bevacizumab Drug: LIVERPEARLS-Irinotecan	Phase 2
2	NCT03258541	Rectal cancer	Device: TraceIT® Radiation: Volumetric arc therapy (VMAT) Procedure: Surgery	Not applicable
3	NCT03321396	Submucosal tumor of gastrointestinal tract	Device: sodium alginate mixed with calcium lactate	Not applicable
4	NCT04124588	Nonvariceal upper gastrointestinal bleeding	Device: Nexpowder (hemostatic powder) Device: Conventional technique	Not applicable
5	NCT04062721	Unresectable colorectal liver metastases	Drug: Chemotherapy Procedure: Radiofrequency ablation (RFA) Drug: In-situ immunotherapy	Phase 1